HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco: Market Multiplier for Personalized Medicine

Executive Summary

Medco is developing data that could accelerate the adoption of personalized medicine--as a way to make itself more relevant to customers and the lives they represent. Armed with infrastructure from its mail pharmacy business and access to medical information on large groups of people, it is financing and conducting studies to show the value of pharmacogenomic tests in improving clinical outcomes. By so doing, it could become an incredible enabler of companies pursuing personalized medicine.

You may also be interested in...



Express Scripts-Medco Deal Showcases New Post-Health Reform Reality

Express Scripts' merger agreement with Medco Health Solutions to form a mega-pharmacy benefits manager fits the new realities of the post-health care reform world. Together, the two PBMs managed more than 1.7 billion prescription claims for approximately 135 million individuals in 2010; thus, the tie-up, which was announced July 21, creates an entity that dominates the PBM space by a wide margin, with CVS Caremark the only other major competitor.

Express Scripts-Medco Deal Showcases New Post-Health Reform Reality

Express Scripts' merger agreement with Medco Health Solutions to form a mega-pharmacy benefits manager fits the new realities of the post-health care reform world. Together, the two PBMs managed more than 1.7 billion prescription claims for approximately 135 million individuals in 2010; thus, the tie-up, which was announced July 21, creates an entity that dominates the PBM space by a wide margin, with CVS Caremark the only other major competitor.

Medco Buys DNA Direct To Bolster Personalized Medicine Business

Medco's purchase of DNA Direct, announced Feb. 2, will enable the pharmacy benefits manager to grow its personalized medicine business by adding decision support services for payors, providers and patients

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

IV002883

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel